Clinical characteristics and treatment outcomes of HER2 mutation and HER2 fusion in 22 patients with advanced breast cancer by Yuxin Mu, Yanchun Meng, Yiqun Du, Xiaojun Liu, Jian Zhang

Get full text

The RRP9-JUN axis promotes breast cancer progression via the AKT signalling pathway by Jinliang Huan, Xiaojun Liu, Na Wang, Yuxin Mu, Ling Li, Yiqun Du

Get full text

Phase I dose escalation study and pilot efficacy analysis of LXI-15029, a novel mTOR dual inhibitor, in Chinese subjects with advanced malignant solid tumors by Jiani Wang, Lin Gui, Yuxin Mu, Jiayu Wang, Yihebali Chi, Zhenteng Liu, Qing Li, Binghe Xu

Get full text

Results and exploratory biomarker analyses of a phase II study CHANGEABLE: combination of HX008 and niraparib in GErm-line-mutAted metastatic breast cancer by Yizi Jin, Yiqun Du, Yanchun Meng, Xuchen Shao, Xiaojun Liu, Yuxin Mu, Yun Liu, Zhen Hu, Jian Zhang

Get full text

Effects of Lactiplantibacillus plantarum on oxidative stress, mitophagy, and NLRP3 inflammasome activation in broiler breast meat by Junmeng Yuan, Fan Zhao, Yu Liu, Huawei Liu, Kai Zhang, Xinyu Tian, Yuxin Mu, Jinshan Zhao, Yang Wang

Get full text

Artificial Intelligence-Enabled ECG Algorithm Based on Improved Residual Network for Wearable ECG by Hongqiang Li, Zhixuan An, Shasha Zuo, Wei Zhu, Zhen Zhang, Shanshan Zhang, Cheng Zhang, Wenchao Song, Quanhua Mao, Yuxin Mu, Enbang Li, Juan Daniel Prades García

Get full text

First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors by Jian Zhang, Yiqun Du, Yanchun Meng, Xiaojun Liu, Yuxin Mu, Yunpeng Liu, Yehui Shi, Jufeng Wang, Aimin Zang, Shanzhi Gu, Tianshu Liu, Huan Zhou, Hongqian Guo, Silong Xiang, Xialu Zhang, Suqiong Wu, Huanhuan Qi, Mengke Li, Xichun Hu

Get full text